Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Irritable Bowel Syndrome, April 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 96 articles:
HTML format


 

Single Articles

  1. WANG ZY, Ma DR, Li MJ, Liang YY, et al
    Association between irritable bowel syndrome and Parkinson's disease by Cohort study and Mendelian randomization analysis.
    NPJ Parkinsons Dis. 2024;10:70.
    PubMed    
    Abstract available

  2. MING X, Gao S, Sun J, Zhang N, et al
    Regulation of the MCHergic Neural Circuit to Dorsal Raphe Nucleus on Emotion-Related Behaviors and Intestinal Dysfunction in Mice Model of Irritable Bowel Syndrome with Diarrhea.
    Neuroendocrinology. 2024 Mar 28. doi: 10.1159/000538582.
    PubMed    
    Abstract available

  3. MIRON RJ, Estrin NE, Sculean A, Zhang Y, et al
    Understanding exososmes: Part 3-therapeutic + diagnostic potential in dentistry.
    Periodontol 2000. 2024 Mar 28. doi: 10.1111/prd.12557.
    PubMed    
    Abstract available

  4. XIE X, He J, Xu S, Xu Z, et al
    Psychological factors may affect the quality of life in irritable bowel syndrome patients more than the gut itself? A multicenter cross-sectional study.
    JGH Open. 2024;8:e13045.
    PubMed    
    Abstract available

  5. GARBATI P, Picco C, Magrassi R, Signorello P, et al
    Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers.
    Pharmaceutics. 2024;16:431.
    PubMed    
    Abstract available

  6. RURGO S, Marchili MR, Spina G, Roversi M, et al
    Prevalence of Rome IV Pediatric Diagnostic Questionnaire-Assessed Disorder of Gut-Brain Interaction, Psychopathological Comorbidities and Consumption of Ultra-Processed Food in Pediatric Anorexia Nervosa.
    Nutrients. 2024;16:817.
    PubMed    
    Abstract available

  7. RAU S, Gregg A, Yaceczko S, Limketkai B, et al
    Prebiotics and Probiotics for Gastrointestinal Disorders.
    Nutrients. 2024;16:778.
    PubMed    
    Abstract available

  8. CHEN J, Zhao T, Li H, Xu W, et al
    Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome.
    Int J Mol Sci. 2024;25:3514.
    PubMed    
    Abstract available

  9. TABORI H, Barucha A, Zagoya C, Duckstein F, et al
    Scoring Abdominal Symptoms in People with Cystic Fibrosis.
    J Clin Med. 2024;13:1650.
    PubMed    
    Abstract available

  10. XENOPOULOU E, Kontele I, Sergentanis TN, Grammatikopoulou MG, et al
    Biotics and Children's and Adolescents' Health: A Narrative Review.
    Children (Basel). 2024;11:329.
    PubMed    
    Abstract available

  11. UBEDA F, Santander S, Luesma MJ
    Clinical Practice Guidelines for the Diagnosis and Management of Hereditary Fructose Intolerance.
    Diseases. 2024;12:44.
    PubMed    
    Abstract available

  12. ZHOU S, Sun Q, Gao N, Hu Z, et al
    The Role of Inflammatory Biomarkers in Mediating the Effect of Inflammatory Bowel Disease on nonmalignant Digestive System Diseases: A Multivariable Mendelian Randomized Study.
    Can J Gastroenterol Hepatol. 2024;2024:1266139.
    PubMed    
    Abstract available

  13. HIDAYAT AA, Waskito LA, Sugihartono T, Aftab H, et al
    Diagnostic strategy of irritable bowel syndrome: a low- and middle-income country perspective.
    Intest Res. 2024 Mar 26. doi: 10.5217/ir.2023.00199.
    PubMed    
    Abstract available

  14. COSTA DVS, Pham NV, Loureiro AV, Yang SE, et al
    Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease.
    Anaerobe. 2024 Mar 23:102837. doi: 10.1016/j.anaerobe.2024.102837.
    PubMed    
    Abstract available

  15. ERFAN A, Aghaei A, Golparvar M
    Effectiveness of Group Emotional Schema Therapy on Psychological Distress, Severity and Frequency of Symptoms in Women with Irritable Bowel Syndrome.
    Adv Biomed Res. 2024;13:11.
    PubMed    
    Abstract available

  16. POURKAZEM T, Ghazanfari A, Ahmadi R
    Comparison of the Effectiveness of Mindfulness-Based Stress Reduction and Compassion-Focused Therapy on the Cognitive Emotion Regulation in Patients with Irritable Bowel Syndrome.
    Middle East J Dig Dis. 2023;15:277-284.
    PubMed    
    Abstract available

  17. BANERJEE A, Sarkhel S, Dhali GK, Paul I, et al
    A follow-up study of anxiety and depressive symptoms in irritable bowel syndrome.
    Indian J Psychiatry. 2024;66:142-147.
    PubMed    
    Abstract available

  18. CHEN M, Wei W, Li Y, Ge S, et al
    Cholestyramine alleviates bone and muscle loss in irritable bowel syndrome via regulating bile acid metabolism.
    Cell Prolif. 2024 Mar 25:e13638. doi: 10.1111/cpr.13638.
    PubMed    
    Abstract available

  19. SUN Y, Nan H, Zhang C, Yang X, et al
    Genetic characteristics of Blastocystis sp. in cattle from Hebei Province, China.
    Microb Pathog. 2024;190:106629.
    PubMed    
    Abstract available

  20. WU S, Yang Z, Liu S, Zhang Q, et al
    Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study.
    Clin Gastroenterol Hepatol. 2024 Mar 21:S1542-3565(24)00168.
    PubMed    
    Abstract available

  21. OUYANG L, Liu T, He Y, He Y, et al
    A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D).
    J Ethnopharmacol. 2024;328:118050.
    PubMed    
    Abstract available

  22. ZHAO Y, Zhan J, Sun C, Zhu S, et al
    Sishen Wan enhances intestinal barrier function via regulating endoplasmic reticulum stress to improve mice with diarrheal irritable bowel syndrome.
    Phytomedicine. 2024;129:155541.
    PubMed    
    Abstract available

  23. CONLEY TE, Parkes M, Moss S, Probert C, et al
    Assessing 'response' to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?
    Clin Nutr. 2024;43:1079-1086.
    PubMed    
    Abstract available

  24. YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al
    Multimorbidity of Allergic Diseases Is Associated With Functional Gastrointestinal Disorders in a Young Japanese Population.
    J Neurogastroenterol Motil. 2024;30:229-235.
    PubMed    
    Abstract available

  25. NAKAYA K, Nakaya N, Kogure M, Hatanaka R, et al
    Factors Associated With the Prevalence of Irritable Bowel Syndrome: The Miyagi Part of the Tohoku Medical Megabank Project Community-based Cohort Study.
    J Neurogastroenterol Motil. 2024;30:208-219.
    PubMed    
    Abstract available

  26. KIM NH, Choi HS, Lee MY, Seong H, et al
    The Effects of Fermented Rice Drink With Lactiplantibacillus plantarum JSA22 in Overweight Irritable Bowel Syndrome Patients: A Randomized, Double-blind, Placebo-controlled Study.
    J Neurogastroenterol Motil. 2024;30:194-207.
    PubMed    
    Abstract available

  27. CHOI SI, Kim N, Nam RH, Jang JY, et al
    Sex Difference in the Effect of Bifidobacterium longum on Repeated Water Avoidance Stress-induced Gut Dysbiosis in Wistar Rats.
    J Cancer Prev. 2024;29:16-23.
    PubMed    
    Abstract available

  28. HUONG BT, Hien NM, Dung NT, Quang DM, et al
    Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
    Med Arch. 2024;78:105-111.
    PubMed    
    Abstract available

  29. WANG Y, Zhu J, Tang Y, Huang C, et al
    Association of periodontitis with gastrointestinal tract disorders: A bidirectional Mendelian randomization study.
    J Periodontol. 2024 Apr 2. doi: 10.1002/JPER.23-0560.
    PubMed    
    Abstract available

  30. GELLER S, Levy S, Avitsur R
    Psychological distress in individuals with irritable bowel syndrome: the roles of body image and self-criticism.
    Health Psychol Behav Med. 2024;12:2334466.
    PubMed    
    Abstract available

  31. CHEN W, Liao L, Huang Z, Lu Y, et al
    Corrigendum: Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats.
    Front Pharmacol. 2024;15:1394753.
    PubMed    
    Abstract available

  32. HASSAN R, Singh P, Ballou S, Rangan V, et al
    Prevalence and determinants of postprandial diarrhea in a tertiary care center.
    Neurogastroenterol Motil. 2024 Apr 1:e14792. doi: 10.1111/nmo.14792.
    PubMed    
    Abstract available

  33. VASAPOLLI R, Krikonas S, Macke L, Gravdal K, et al
    Prolonged Intake of Luvos Healing Earth does not alter the Composition of the Gut Microbiota in Patients with Diarrhea-predominant Irritable Bowel Syndrome and Healthy Controls.
    J Gastrointestin Liver Dis. 2024;33:30-36.
    PubMed    
    Abstract available

  34. GUNASINGHA RMKD, Herrick-Reynolds K, Sanford JA, Radowsky J, et al
    Iatrogenic immunodeficiency-associated lymphoproliferative disorder presenting as small bowel perforation.
    BMJ Case Rep. 2024;17:e257148.
    PubMed    
    Abstract available

  35. ROMETSCH C, Mansueto G, Maas Genannt Bermpohl F, Martin A, et al
    Prevalence of functional disorders across Europe: a systematic review and meta-analysis.
    Eur J Epidemiol. 2024 Mar 29. doi: 10.1007/s10654-024-01109.
    PubMed    
    Abstract available

  36. ZUGASTI MURILLO A
    Diet low in fodmaps: fundamentals, evidence and controversies.
    Endocrinol Diabetes Nutr (Engl Ed). 2024;71:41-43.
    PubMed    


  37. SULTAN N, Foyster M, Tonkovic M, Noon D, et al
    Presence and characteristics of disordered eating and orthorexia in irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 12:e14797. doi: 10.1111/nmo.14797.
    PubMed    
    Abstract available

  38. PEREYRA F, Bustos Fernandez LM, Schlottmann F, Zamora R, et al
    Prevalence of extra-intestinal symptoms according to irritable bowel syndrome subtype.
    Neurogastroenterol Motil. 2024 Apr 12:e14796. doi: 10.1111/nmo.14796.
    PubMed    
    Abstract available

  39. MATTIO N, Pradat P, Machon C, Mialon A, et al
    Glucose breath test for the detection of small intestine bacterial overgrowth: Impact of diet prior to the test.
    Neurogastroenterol Motil. 2024 Apr 12:e14801. doi: 10.1111/nmo.14801.
    PubMed    
    Abstract available

  40. LI J, Fong DYT, Lok KYW, Wong JYH, et al
    Key lifestyles and health outcomes across 16 prevalent chronic diseases: A network analysis of an international observational study.
    J Glob Health. 2024;14:04068.
    PubMed    
    Abstract available

  41. MORGAN RK, Wynn A, Hanisee MK
    Pneumatosis Cystoides Intestinalis Discovered During Exploratory Laparotomy.
    Cureus. 2024;16:e56032.
    PubMed    
    Abstract available

  42. STALLMACH A, Quickert S, Puta C, Reuken PA, et al
    The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
    Front Immunol. 2024;15:1352744.
    PubMed    
    Abstract available

  43. SHAFIEI F, Dehghani M, Lavasani FF, Manouchehri M, et al
    Intensive short-term dynamic psychotherapy for irritable bowel syndrome: a randomized controlled trial examining improvements in emotion regulation, defense mechanisms, quality of life, and IBS symptoms.
    Front Psychol. 2024;15:1293150.
    PubMed    
    Abstract available

  44. ALSMADI MM, Abudaqqa AA, Idkaidek N, Qinna NA, et al
    The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling.
    AAPS PharmSciTech. 2024;25:86.
    PubMed    
    Abstract available

  45. UTZ S, Bittel M, Langhorst J
    [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review].
    Z Gastroenterol. 2024 Apr 11. doi: 10.1055/a-2279-5045.
    PubMed    
    Abstract available

  46. SELKER RJDM, Koppert TY, Houtveen JH, Geenen R, et al
    Psychological flexibility in somatic symptom and related disorders: A case control study.
    J Psychiatr Res. 2024;173:398-404.
    PubMed    
    Abstract available

  47. LEMBO AJ, Edelstein S, Rosenbaum DP, Rooker C, et al
    Long-term safety of tenapanor in people with irritable bowel syndrome with constipation from the T3MPO-3 study: plain language summary of publication.
    Therap Adv Gastroenterol. 2024;17:17562848241237196.
    PubMed    


  48. WU H, Li J, Li F, Lun W, et al
    Causal association of gastroesophageal reflux disease on irritable bowel syndrome: a two-sample Mendelian randomization study.
    Front Genet. 2024;15:1328327.
    PubMed    
    Abstract available

  49. KATSUMATA R, Kaburagi T, Hosokawa T, Manabe N, et al
    Different Food Preferences in Patients with Gastrointestinal Disorders.
    Intern Med. 2024 Apr 9. doi: 10.2169/internalmedicine.3433.
    PubMed    
    Abstract available

  50. LI ZY, Mao YQ, Hua Q, Sun YH, et al
    Serotonin receptor 2B induces visceral hyperalgesia in rat model and patients with diarrhea-predominant irritable bowel syndrome.
    World J Gastroenterol. 2024;30:1431-1449.
    PubMed    
    Abstract available

  51. LAI T, Luo C, Yuan Y, Fang J, et al
    Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis.
    Int J Chron Obstruct Pulmon Dis. 2024;19:873-886.
    PubMed    
    Abstract available

  52. RODRIGUEZ-PALMA EJ, Huerta de la Cruz S, Islas-Espinoza AM, Castaneda-Corral G, et al
    Nociplastic pain mechanisms and toll-like receptors as promising targets for its management.
    Pain. 2024 Apr 5. doi: 10.1097/j.pain.0000000000003238.
    PubMed    
    Abstract available

  53. MAJUMDAR D, Webb D, Parsons S, Selwan-Lewis EM, et al
    Understanding preferences for receiving health communications and information about clinical trials: a cross-sectional study among US adults.
    Curr Med Res Opin. 2024 Apr 10:1-13. doi: 10.1080/03007995.2024.2340720.
    PubMed    
    Abstract available

  54. YAN XX, Zhang YL, Zhang YP, Yang YY, et al
    Diagnostic Accuracy of Computerized Bowel Sound Analysis with Non-Invasive Devices for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Chin Med Sci J. 2024 Apr 10. doi: 10.24920/004307.
    PubMed    
    Abstract available

  55. LEE C, Rao S, Cabral HJ, Weber HC, et al
    Co-Morbidities of Irritable Bowel Syndrome in a Racially and Ethnically Diverse Population.
    J Clin Med. 2024;13:1482.
    PubMed    
    Abstract available

  56. CHENG K, Lee C, Garniene R, Cabral H, et al
    Epidemiology of Irritable Bowel Syndrome in a Large Academic Safety-Net Hospital.
    J Clin Med. 2024;13:1314.
    PubMed    
    Abstract available

  57. CHIARELLI M, De Simone M, Cioffi G, Cioffi U, et al
    New paradigm of oral rehydration in patients affected by irritable bowel syndrome with chronic diarrhea.
    World J Gastrointest Pharmacol Ther. 2024;15:90933.
    PubMed    
    Abstract available

  58. HAN XY, Song XG, Ma WL, Fang M, et al
    Electroacupuncture protects the intestinal mucosal barrier in diarrhea-predominant Irritable Bowel Syndrome rats by regulating the MCs/Tryptase/PAR-2/MLCK pathway.
    Am J Transl Res. 2024;16:781-793.
    PubMed    
    Abstract available

  59. CANTRELL C, Reid C, Walker CS, Stallkamp Tidd SJ, et al
    Post-COVID postural orthostatic tachycardia syndrome (POTS): a new phenomenon.
    Front Neurol. 2024;15:1297964.
    PubMed    
    Abstract available

  60. CHEN J, Ruan X, Fu T, Lu S, et al
    Sedentary lifestyle, physical activity, and gastrointestinal diseases: evidence from mendelian randomization analysis.
    EBioMedicine. 2024;103:105110.
    PubMed    
    Abstract available

  61. ZINK N
    [Not Available].
    MMW Fortschr Med. 2024;166:10.
    PubMed    


  62. MA X, Huan H, Liu C, Hu H, et al
    Influence of ethnic origin on the clinical characteristics and intestinal flora of irritable bowel syndrome: a prospective study between Han and Tibetan patients.
    Front Med (Lausanne). 2024;11:1359962.
    PubMed    
    Abstract available

  63. GOSTOLI S, Ferrara F, Quintavalle L, Tommasino S, et al
    Four-year follow-up of psychiatric and psychosomatic profile in patients with Inflammatory Bowel Disease (IBD).
    BMC Psychol. 2024;12:211.
    PubMed    
    Abstract available

  64. WYATT NJ, Watson H, Anderson CA, Kennedy NA, et al
    Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.
    BMJ Open. 2024;14:e073639.
    PubMed    
    Abstract available

  65. SRIVASTAVA S, Basak U, Naghibi M, Vijayakumar V, et al
    A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel
    Gut Microbes. 2024;16:2338322.
    PubMed    
    Abstract available

  66. THOMAS BS, Perry D, Moe SS, Turgeon RD, et al
    Top studies of 2023 relevant to primary care: From the PEER team.
    Can Fam Physician. 2024;70:245-248.
    PubMed    
    Abstract available

  67. MCKAY DM, Defaye M, Rajeev S, MacNaughton WK, et al
    Neuroimmunophysiology of the Gastrointestinal Tract.
    Am J Physiol Gastrointest Liver Physiol. 2024.
    PubMed    
    Abstract available

  68. NAGAMINE T
    Amitriptyline at low dose for burning mouth syndrome.
    Oral Dis. 2024 Apr 15. doi: 10.1111/odi.14966.
    PubMed    


  69. LUO Y, Luo CL, Meislin R, Yang E, et al
    Psychological comorbidities are more prevalent amongst pregnant and postpartum patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 15:e14800. doi: 10.1111/nmo.14800.
    PubMed    
    Abstract available

  70. LACY BE, Gagnon-Sanschagrin P, Heimanson Z, Bungay R, et al
    Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea.
    Adv Ther. 2024 Apr 15. doi: 10.1007/s12325-024-02832.
    PubMed    
    Abstract available

  71. KOHLMEIER M, Baah E, Washko M, Adams K, et al
    Genotype-informed nutrition counselling in clinical practice.
    BMJ Nutr Prev Health. 2023;6:407-412.
    PubMed    


  72. ALAWI Z, AlMakna W, Hassan F, Faisal M, et al
    Prevalence of Isolated Irritable Bowel Syndrome Among Adults in the Kingdom of Bahrain.
    Cureus. 2024;16:e56155.
    PubMed    
    Abstract available

  73. SINGH P, Sayuk GS, Rosenbaum DP, Edelstein S, et al
    An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation.
    Clin Exp Gastroenterol. 2024;17:87-96.
    PubMed    
    Abstract available

  74. CHANG X, Zhang H, Chen S
    Neural circuits regulating visceral pain.
    Commun Biol. 2024;7:457.
    PubMed    
    Abstract available

  75. LUSETTI F, Schiepatti A, Scalvini D, Maimaris S, et al
    Efficacy of a Low-FODMAP Diet for Coeliac Patients with Persistent IBS-like Symptoms despite a Gluten-Free Diet: A Systematic Review.
    Nutrients. 2024;16:1094.
    PubMed    
    Abstract available

  76. MUSCOGIURI G, De Marco O, Di Lorenzo T, Amicone M, et al
    Diet and Physical Activity in Fabry Disease: A Narrative Review.
    Nutrients. 2024;16:1061.
    PubMed    
    Abstract available

  77. MAQOUD F, Orlando A, Tricarico D, Antonacci M, et al
    Anti-Inflammatory Effects of a Novel Acetonitrile-Water Extract of Lens Culinaris against LPS-Induced Damage in Caco-2 Cells.
    Int J Mol Sci. 2024;25:3802.
    PubMed    
    Abstract available

  78. KIM HY, Kim CE, Oh DR, Kim Y, et al
    Development and Validation of a High-Performance Liquid Chromatography Method to Quantify Marker Compounds in Lysimachia vulgaris var. davurica and Its Effects in Diarrhea-Predominant Irritable Bowel Syndrome.
    Molecules. 2024;29:1489.
    PubMed    
    Abstract available

  79. SEIDITA A, Giuliano A, Soresi M, Chiavetta M, et al
    Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept.
    Intern Emerg Med. 2024 Apr 12. doi: 10.1007/s11739-024-03595.
    PubMed    
    Abstract available

  80. ISHIOH M, Nozu T, Miyagishi S, Igarashi S, et al
    Brain histamine improves colonic hyperpermeability through the basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats.
    Biochem Pharmacol. 2024;224:116201.
    PubMed    
    Abstract available

  81. ALIU A, Bosch DHCA, Keszthelyi D, Rezazadeh Ardabili A, et al
    Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission.
    Aliment Pharmacol Ther. 2024 Apr 8. doi: 10.1111/apt.17988.
    PubMed    
    Abstract available

  82. BARRY HC
    Amitriptyline as Second-Line Therapy Improves Symptoms in Adults With Irritable Bowel Syndrome.
    Am Fam Physician. 2024;109:Online.
    PubMed    


  83. CASH BD
    Congratulations. You Have Irritable Bowel Syndrome.
    Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002734.
    PubMed    


  84. HANNA-JAIRALA I, Drossman DA
    CENTRAL NEUROMODULATORS IN IRRITABLE BOWEL SYNDROME. WHY, HOW AND WHEN.
    Am J Gastroenterol. 2024 Apr 9. doi: 10.14309/ajg.0000000000002800.
    PubMed    
    Abstract available

  85. ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
    Gastroenterology/Hepatology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
    PubMed    
    Abstract available

  86. BRENNER DM, Sharma A, Rao SSC, Laitman AP, et al
    Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
    Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08330.
    PubMed    
    Abstract available

  87. MATSUMURA T, Sonoda M, Okimoto K, Dao HV, et al
    Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
    Dig Dis Sci. 2024 Apr 15. doi: 10.1007/s10620-024-08411.
    PubMed    
    Abstract available

  88. EL-SALHY M, Hatlebakk JG
    Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms.
    Dig Dis Sci. 2024;69:1336-1344.
    PubMed    
    Abstract available

  89. SADEGHIAN AM, Dashti F, Shariati B, Mokhtare M, et al
    The role of cognitive emotion regulation strategies in predicting the resilience, symptom severity, and quality of life of patients with irritable bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2024 Apr 9:102341.
    PubMed    
    Abstract available

  90. BABIKOW L, Fawcett TN, Pfeifer E, Berry S, et al
    Integrated Virtual Care for Irritable Bowel Syndrome: A Qualitative Study.
    Gastroenterol Nurs. 2024;47:85-91.
    PubMed    
    Abstract available

  91. CHOGLE A, El-Chammas K, Santucci N, Grimm M, et al
    A multicenter registry study on percutaneous electrical nerve field stimulation for pediatric disorders of gut-brain interaction.
    J Pediatr Gastroenterol Nutr. 2024;78:817-826.
    PubMed    
    Abstract available

  92. OPP J, Schurmann M, Jenke A, Job B, et al
    Drawing the abdominal pain: A powerful tool to distinguish between organic and functional abdominal pain.
    J Pediatr Gastroenterol Nutr. 2024;78:846-852.
    PubMed    
    Abstract available

  93. RAUMA J, Jansson S, Cao Y, van Nieuwenhoven MA, et al
    A comparison of Swedish IBS patients and general practitioners regarding viewpoints on IBS: a Q-methodology study.
    Scand J Gastroenterol. 2024 Apr 1:1-7. doi: 10.1080/00365521.2024.2328590.
    PubMed    
    Abstract available

  94. EL-SALHY M, Gilja OH, Hatlebakk JG
    Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females.
    Scand J Gastroenterol. 2024;59:391-400.
    PubMed    
    Abstract available

  95. DAI X, Liang M, Dai Y, Ding S, et al
    Causality of genetically determined blood metabolites on irritable bowel syndrome: A Mendelian randomization study.
    PLoS One. 2024;19:e0298963.
    PubMed    
    Abstract available

  96. GUO Y, Lu Q, Yang XJ, He Y, et al
    Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity.
    PLoS One. 2024;19:e0299376.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;